About us Contact Terms of Use Data Sources Publications FAQ
ADH1B logo

ADH1B

All-trans-retinol dehydrogenase [NAD(+)] ADH1B

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 3.13 1.60 1.08 0.64 -0.25 126 2.89 2.55 2.43 2.30 -0.09 -1.35
Bladder (BLCA) 406 2.64 1.12 0.44 -0.71 -0.00 9 3.05 2.99 2.91 2.64 2.35 -2.46
Breast (BRCA) 1067 2.93 1.78 1.30 0.54 -0.00 178 3.82 3.37 3.08 2.82 1.96 -1.78
Cervical (CESC) 297 2.35 0.14 -0.71 -0.38 -0.01 10 2.54 2.37 2.21 1.89 1.41 -2.92
Cholangiocarcinoma (CHOL) 36 2.89 2.11 1.62 0.98 -0.08 0
Colon (COAD) 443 2.53 1.11 0.64 0.14 -0.00 166 3.47 2.71 2.52 2.35 -0.09 -1.87
B-cell lymphoma (DLBC) 42 1.81 1.12 0.62 0.15 -0.18 337 3.10 1.35 1.05 0.82 0.07 -0.43
Esophageal (ESCA) 142 2.25 1.15 0.45 0.02 -0.01 271 3.11 2.53 2.39 2.26 -0.09 -1.94
Glioblastoma (GBM) 160 1.37 0.21 -0.58 -0.28 -0.00 214 1.72 0.83 0.65 0.53 -0.05 -1.23
Head and neck (HNSC) 432 1.81 0.40 -0.73 -0.44 -0.01 55 2.80 2.46 2.19 1.85 0.99 -2.92